Human T-cell leukemia virus type 1 (HTLV-1), the first human retrovirus to be discovered, is
present in diverse regions of the world, where its infection is usually neglected in health care …

Oncoviruses are implicated in approximately 12% of all human cancers. A large number of
the world's population harbors at least one of these oncoviruses, but only a small proportion …

Human T-cell leukemia virus type 1 (HTLV-1) is the causal agent of a neoplastic disease of
CD4+ T cells, adult T-cell leukemia (ATL), and inflammatory diseases including HTLV-1 …

The human T-cell leukemia virus type 1 (HTLV-1) was the first retrovirus discovered to be
causative of a human cancer, adult T-cell leukemia. The transforming entity of HTLV-1 has …

Human T cell leukemia virus type 1 (HTLV-1) is an oncogenic retrovirus responsible for the
development of adult T-cell leukemia (ATL). Although HTLV-1 harbors an oncogene, tax …

Human T lymphotropic virus type 1 (HTLV-1) is one of the most intriguing retroviruses
infecting humans. Most commonly, infection remains undetected, since it does not cause …

In 1980, HumanT cell leukemia/lymphoma virus type 1 (HTLV-1) was the first oncogenic
human retrovirus to be discovered. HTLV-1 belongs to the Retroviridae family, the …

Human T-cell leukemia virus type 1 (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL)
and is also associated with a variety of lymphocyte-mediated diseases. The HTLV-1 basic …

CD8+ T cells can exert both protective and harmful effects on the virus-infected host.
However, there is no systematic method to identify the attributes of a protective CD8+ T cell …

Background: The human leukaemia virus HTLV-1 expresses essential accessory genes that
manipulate the expression, splicing and transport of viral mRNAs. Two of these genes, tax …